Biosimilar Symposium
Expired

  • June 5, 2018
    8:30 am - 5:00 pm

Location

6250 Highway 7, Vaughan, Ontario, Canada, L4H 4G3

Certification Areas

           

 

Join us June 5th at the Universal EventSpace in Toronto, ON! Hear directly from regulators through an exclusive line up of Health Canada’s Biologics & Genetic Therapies Directorate (BGTD) department as well as the FDA.

Here’s a SNEAK PEAK at our Symposium Program and speakers!

 

Topic 1: Biosimilars Regulation & Update on Key Activities

Dr. Emily Griffiths
Subject Matter/Technical Specialist
Office of Policy and International Collaboration
Biologics and Genetic Therapies Directorate

 

Topic 2: Interchangeability

Dr. Sue Lim
Medical Officer, Team Leader
Office of New Drugs Therapeutics Biologics and Biosimilars Staff
Centre for Drug Evaluation and Research
U.S. Food and Drug Administration

 

Topic 3: Best Practices when Filing Biosimilar Submissions

Jemma Fraijé
Regulatory Affairs Supervisor
Office of Regulatory Affairs
Biologics and Genetic Therapies Directorate

 

Topic 4: Inflectra Case Study

Dr. Sue Lim
Medical Officer, Team Leader
Office of New Drugs Therapeutics Biologics and Biosimilars Staff
Centre for Drug Evaluation and Research
U.S. Food and Drug Administration

 

Topic 5: Quality Evaluation of Biosimilars

Dr. Wallace Lauzon
Chief, Cytokines Division
Centre for Evaluation of Radiopharmaceuticals and Biotherapeutics
Biologics and Genetic Therapies Directorate

 

Topic 6: Non-Clinical & Clinical Evaluations of Biosimilars

Dr. Jian Wang
Chief, Clinical Evaluation Division
Centre for Evaluation of Radiopharmaceuticals and Biotherapeutics
Biologics and Genetic Therapies Directorate

 

 

Gold Sponsor:

 

 

 

Silver Sponsor:

 

 

 

Also Sponsored by:

 

          

 

Our Partners:



PSG Member: $545.00 Sold Out
PSG Non-Member: $595.00 Sold Out
Corporate +5: $500.00 Sold Out
Corporate +10: $450.00 Sold Out
Health Canada: $500.00 Sold Out
Student: $200.00 Sold Out